Eli Lilly and Company Net Income 2007–2025
Eli Lilly and Company (LLY) annual net income by fiscal year, computed from SEC filings. Compound growth +11.4%/yr over 18 years.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $20.64B | 31.7% | +94.9% |
| FY 2024 | $10.59B | 23.5% | +102.1% |
| FY 2023 | $5.24B | 15.4% | -16.1% |
| FY 2022 | $6.24B | 21.9% | +11.9% |
| FY 2021 | $5.58B | 19.7% | -9.9% |
| FY 2020 | $6.19B | 25.2% | -25.5% |
| FY 2019 | $8.32B | 37.3% | +157.4% |
| FY 2018 | $3.23B | 15.0% | +1683.5% |
| FY 2017 | $-204.10M | -1.0% | -107.5% |
| FY 2016 | $2.74B | 12.9% | +13.7% |
| FY 2015 | $2.41B | 12.1% | +0.7% |
| FY 2014 | $2.39B | 12.2% | -49.0% |
| FY 2013 | $4.68B | 20.3% | +14.6% |
| FY 2012 | $4.09B | 18.1% | -6.0% |
| FY 2011 | $4.35B | 17.9% | -14.2% |
| FY 2010 | $5.07B | 22.0% | +17.1% |
| FY 2009 | $4.33B | 19.8% | +308.9% |
| FY 2008 | $-2.07B | -10.2% | -170.2% |
| FY 2007 | $2.95B | 15.8% | — |
Source: Eli Lilly and Company SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Eli Lilly and Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEli Lilly and Company — frequently asked questions
What is Eli Lilly and Company's net income?
Eli Lilly and Company (LLY) reported net income of $20.64B for fiscal year 2025, per its SEC filings.
How has Eli Lilly and Company's net income changed over time?
Between fiscal 2007 and 2025, LLY's net income grew at roughly 11.4% per year (compound annual rate), from $2.95B to $20.64B.
Where does this data come from?
Figures are computed from Eli Lilly and Company's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.